tyrosine has been researched along with Bile Duct Cancer in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (25.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (37.50) | 29.6817 |
2010's | 1 (12.50) | 24.3611 |
2020's | 2 (25.00) | 2.80 |
Authors | Studies |
---|---|
Alva-Ruiz, R; Borad, M; Buckarma, EH; Buijsman, RC; Conboy, CB; de Man, J; Gores, GJ; Graham, RP; Guo, Y; Ilyas, SI; Jessen, E; McCabe, CE; Mun, DG; O'Brien, D; Pandey, A; Smoot, RL; Tomlinson, JL; Truty, MJ; Vu, D; Wang, J; Watkins, RD; Werneburg, NW; Yonkus, JA | 1 |
Chang, HW; Chang, VHS; Chien, LN; Chu, PG; Dong, F; Jia, W; Lin, IH; Liu, YR; Wu, MJ; Xie, G; Yang, YSH; Yen, Y | 1 |
Blechacz, BR; Bronk, SF; Gores, GJ; Sirica, AE; Smoot, RL; Werneburg, NW | 1 |
Gui, A; Kitazawa, M; Kobayashi, A; Miyagawa, S; Motoyama, H; Takeoka, M | 1 |
DePinho, RA; Farazi, PA; Glickman, J; Kalluri, R; Zeisberg, M; Zhang, Y | 1 |
Bronk, SF; Gores, GJ; Haan, S; Isomoto, H; Kobayashi, S; Mott, JL; Werneburg, NW | 1 |
Finegold, MJ; Weinberg, AG | 1 |
Alvarez-Prechous, A; Díaz-Cardama, A; Lema, M; Noya, M | 1 |
2 review(s) available for tyrosine and Bile Duct Cancer
Article | Year |
---|---|
Primary hepatic tumors of childhood.
Topics: Adenocarcinoma; Adenoma; Adolescent; Adult; Bile Duct Neoplasms; Bile Ducts; Carcinoma, Hepatocellular; Child; Child, Preschool; Female; Hemangioma; Hemangiosarcoma; Hepatitis; Hepatitis B; Humans; Hyperplasia; Infant; Liver Cirrhosis, Biliary; Liver Neoplasms; Male; Metabolism, Inborn Errors; Neoplasms, Germ Cell and Embryonal; Prognosis; Sex Factors; Tyrosine | 1983 |
[Alpha fetoproteins].
Topics: alpha-Fetoproteins; Amino Acid Metabolism, Inborn Errors; Anencephaly; Ataxia Telangiectasia; Bile Duct Neoplasms; Carcinoma, Hepatocellular; Chemical and Drug Induced Liver Injury; Contraceptives, Oral; Female; Fetal Death; Fetal Proteins; Hepatitis Viruses; Humans; Infant, Newborn; Jaundice, Neonatal; Liver; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Pregnancy; Pregnancy Complications; Prenatal Diagnosis; Spinal Dysraphism; Teratoma; Tyrosine | 1975 |
6 other study(ies) available for tyrosine and Bile Duct Cancer
Article | Year |
---|---|
LCK inhibition downregulates YAP activity and is therapeutic in patient-derived models of cholangiocarcinoma.
Topics: Adaptor Proteins, Signal Transducing; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cell Line, Tumor; Cholangiocarcinoma; Gene Expression Regulation, Neoplastic; Humans; Phosphoproteins; Transcription Factors; Tyrosine; YAP-Signaling Proteins | 2023 |
Long-term Proton Pump Inhibitor Administration Caused Physiological and Microbiota Changes in Rats.
Topics: Administration, Oral; alpha-Tocopherol; Animals; Bile Duct Neoplasms; Bile Ducts; Cell Transformation, Neoplastic; Cholangiocarcinoma; Cholestasis; Feces; Gastrointestinal Microbiome; Gene Expression Regulation; Humans; Omeprazole; Proton Pump Inhibitors; Rats, Wistar; Retinoid X Receptor alpha; RNA-Binding Proteins; RNA, Ribosomal, 16S; Tyrosine | 2020 |
Sorafenib inhibits signal transducer and activator of transcription-3 signaling in cholangiocarcinoma cells by activating the phosphatase shatterproof 2.
Topics: Animals; Apoptosis; Benzenesulfonates; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cell Line, Tumor; Cholangiocarcinoma; Enzyme Activation; Humans; Male; Niacinamide; Phenylurea Compounds; Phosphorylation; Protein Kinase Inhibitors; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Pyridines; Rats; Rats, Inbred F344; Signal Transduction; Sorafenib; STAT3 Transcription Factor; Tyrosine | 2009 |
Impaired degradation followed by enhanced recycling of epidermal growth factor receptor caused by hypo-phosphorylation of tyrosine 1045 in RBE cells.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cell Line, Tumor; Cholangiocarcinoma; Endosomes; Epidermal Growth Factor; ErbB Receptors; Humans; Phosphorylation; Protein Binding; Protein Transport; Proteolysis; Proto-Oncogene Proteins c-cbl; Signal Transduction; Tyrosine; Ubiquitination | 2012 |
Chronic bile duct injury associated with fibrotic matrix microenvironment provokes cholangiocarcinoma in p53-deficient mice.
Topics: Animals; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cadherins; Carbon Tetrachloride Poisoning; Cholangiocarcinoma; Cyclooxygenase 2; Extracellular Matrix; Female; Fibrosis; Germ-Line Mutation; Hyperplasia; Liver Cirrhosis; Male; Mice; Mice, Inbred C57BL; Nitric Oxide Synthase Type II; Proto-Oncogene Proteins c-met; Receptor, ErbB-2; Tumor Suppressor Protein p53; Tyrosine | 2006 |
Sustained IL-6/STAT-3 signaling in cholangiocarcinoma cells due to SOCS-3 epigenetic silencing.
Topics: Apoptosis; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cell Line, Tumor; Cholangiocarcinoma; CpG Islands; DNA Methylation; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; Interleukin-6; Myeloid Cell Leukemia Sequence 1 Protein; Neoplasm Proteins; Phosphorylation; Promoter Regions, Genetic; Proto-Oncogene Proteins c-bcl-2; STAT3 Transcription Factor; Suppressor of Cytokine Signaling 3 Protein; Suppressor of Cytokine Signaling Proteins; TNF-Related Apoptosis-Inducing Ligand; Tyrosine | 2007 |